RIGEL PHARMACEUTICALS INC (RIGL)
US7665597024 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 3.88M | -25.09M | -58.57M | -17.91M | -29.74M | |||
| Depreciation Amortization | 1.91M | 1.24M | 1.00M | 1.16M | 710.00K | |||
| Change In Working Capital | -6.48M | 9.52M | -29.05M | 9.72M | -30.32M | |||
| Interest Paid | 6.97M | 5.85M | 2.50M | 1.50M | 1.18M | |||
| Taxes Paid | N/A | N/A | N/A | 1.50M | 1.18M | |||
| Other non cash items | 11.41M | 8.59M | 12.87M | 12.91M | 7.18M | |||
| OPERATING CASH FLOW | 10.72M | -5.74M | -73.76M | 5.88M | -52.19M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -370.00K | -15.00M | -450.00K | -630.00K | -1.26M | |||
| Other Investing Activity | 8.54M | 10.70M | 73.23M | -79.41M | 48.73M | |||
| INVESTING CASH FLOW | 8.17M | -4.30M | 72.78M | -80.04M | 47.47M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 19.95M | 19.54M | 0.00 | 9.98M | |||
| Stock Issued/Repurchased | 988.00K | 1.05M | 2.12M | 4.78M | 2.60M | |||
| Other Financing Activity | -13.61M | -2.63M | -15.12M | 57.90M | N/A | |||
| FINANCING CASH FLOW | -12.62M | 18.37M | 6.55M | 62.68M | 12.57M | |||
| CHANGE IN CASH | 6.27M | 8.33M | 5.57M | -11.48M | 7.85M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 10.72M | -5.74M | -73.76M | 5.88M | -52.19M | |||
| Capital Expenditure | -370.00K | -15.00M | -450.00K | -630.00K | -1.26M | |||
| FREE CASH FLOW | 10.35M | -20.74M | -74.21M | 5.25M | -53.45M | |||
All data in USD